Advertisement
AMED vs GT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a StrongBuy and GT is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileGT’s FA Score has 0 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- GT’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish while GT’s TA Score has 4 bullish TA indicator(s).
- AMED’s TA Score: 4 bullish, 4 bearish.
- GT’s TA Score: 4 bullish, 6 bearish.
Price Growth
AMED (@Hospital/Nursing Management) experienced а +1.70% price change this week, while GT (@Auto Parts: OEM) price change was -13.68% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +5.93%. For the same industry, the average monthly price growth was -0.10%, and the average quarterly price growth was +7.47%.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was +2.40%. For the same industry, the average monthly price growth was +6.67%, and the average quarterly price growth was +15.38%.
Reported Earning Dates
AMED is expected to report earnings on Oct 29, 2025.
GT is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Hospital/Nursing Management (+5.93% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
@Auto Parts: OEM (+2.40% weekly)OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
| AMED | GT | AMED / GT | |
| Capitalization | 3.32B | 2.45B | 135% |
| EBITDA | 239M | 1.88B | 13% |
| Gain YTD | 11.224 | -4.667 | -241% |
| P/E Ratio | 39.29 | 5.84 | 673% |
| Revenue | 2.4B | 18.6B | 13% |
| Total Cash | 337M | 902M | 37% |
| Total Debt | 451M | 9.04B | 5% |
AMED | GT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 86 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 78 | 84 | |
PRICE GROWTH RATING 1..100 | 51 | 65 | |
P/E GROWTH RATING 1..100 | 37 | 100 | |
SEASONALITY SCORE 1..100 | 31 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GT's Valuation (53) in the Automotive Aftermarket industry is in the same range as AMED (77) in the Medical Or Nursing Services industry. This means that GT’s stock grew similarly to AMED’s over the last 12 months.
GT's Profit vs Risk Rating (100) in the Automotive Aftermarket industry is in the same range as AMED (100) in the Medical Or Nursing Services industry. This means that GT’s stock grew similarly to AMED’s over the last 12 months.
AMED's SMR Rating (78) in the Medical Or Nursing Services industry is in the same range as GT (84) in the Automotive Aftermarket industry. This means that AMED’s stock grew similarly to GT’s over the last 12 months.
AMED's Price Growth Rating (51) in the Medical Or Nursing Services industry is in the same range as GT (65) in the Automotive Aftermarket industry. This means that AMED’s stock grew similarly to GT’s over the last 12 months.
AMED's P/E Growth Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for GT (100) in the Automotive Aftermarket industry. This means that AMED’s stock grew somewhat faster than GT’s over the last 12 months.
| AMED | GT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 36% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 47% | 2 days ago 78% |
| MACD ODDS (%) | 2 days ago 42% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 44% | 2 days ago 74% |
| TrendMonth ODDS (%) | 2 days ago 35% | 2 days ago 74% |
| Advances ODDS (%) | 4 days ago 48% | 23 days ago 72% |
| Declines ODDS (%) | 11 days ago 58% | 3 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 49% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 26% | 2 days ago 73% |
Advertisement
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and ENSG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and ENSG's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | +0.03% | ||
| ENSG - AMED | 25% Poorly correlated | +1.67% | ||
| TALK - AMED | 24% Poorly correlated | +3.20% | ||
| OPCH - AMED | 23% Poorly correlated | -0.04% | ||
| MD - AMED | 21% Poorly correlated | +5.30% | ||
| CYH - AMED | 21% Poorly correlated | +8.20% | ||
More | ||||
GT and
Correlation & Price change
A.I.dvisor indicates that over the last year, GT has been loosely correlated with LIMAF. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GT jumps, then LIMAF could also see price increases.